SCHEMBL8375017

SCHEMBL8375017

CC(C)(C)OC(=O)NCCOc1cc(-c2ccc(Cl)c(Cl)c2)on1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
NOTUM Q6P988 2/20 0.49
LMNA P02545 1/20 0.47
POLB P06746 1/20 0.47
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 2/20 0.41
TP53 P04637 2/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
IDO1 P14902 1/20 0.41
HDAC1 Q13547 4/20 0.40
HDAC6 Q9UBN7 4/20 0.40
HDAC3 O15379 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375763 0.89 IDO1 (0.44) LMNAPOLBMAPTTP53CA12
SCHEMBL8374992 0.88 HDAC1 (0.42) NPC1RAB9ALMNAPOLBMAPT
SCHEMBL8380096 0.87 TP53 (0.57) NPC1RAB9APOLBMAPK1MAPT
SCHEMBL8379534 0.86 TP53 (0.47) NPC1RAB9APOLBTP53CA12
SCHEMBL8375551 0.86 HDAC1 (0.44) NPC1RAB9AHTTMEN1KMT2A
SCHEMBL8378887 0.85 CA12 (0.45) CA12CA1CA2CA9IDO1
SCHEMBL8376903 0.85 TP53 (0.47) NPC1RAB9ALMNAPOLBHTT
SCHEMBL8375557 0.85 BCHE (0.47) CA12CA1CA2CA9IDO1
SCHEMBL8378941 0.85 GABRA5 (0.46) RAB9AMAPK1KMT2ACA12CA1
SCHEMBL8380141 0.84 NPC1 (0.51) NPC1RAB9APOLBMAPK1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed